Former President Jimmy Carter died at home in Plains, Georgia, on December 29, 2024, at age 99. His death followed a series of documented health challenges that began in 2023 with treatment for metastatic melanoma, later complicated by cancers that had spread to his brain. In February 2024, Carter entered home hospice care under a medical order indicating palliative goals and limited life expectancy. Multiple independent sources, including the Carter Center and family statements, confirmed that his passing was surrounded by family and consistent with his expressed wishes for a peaceful, low-profile end. This summary presents verified timelines, diagnoses, and context to clarify how Carter’s health declined and why he died when and how he did.
Key Health Milestones in Carter’s Final Year
Understanding the sequence of Carter’s medical events is central to explaining why he died in late 2024. After decades of robust health, his decline became publicly documented through carefully issued statements from the Carter Center and family. Below is a verified timeline of diagnoses, treatments, and care settings that shaped his final months.
Melanoma Diagnosis and Treatment (Summer 2023)
In August 2023, Carter announced he had been diagnosed with melanoma that had spread to his brain. He underwent surgery to remove a brain mass, followed by radiation treatment and, at one point, immunotherapy with the drug pembrolizumab. These interventions initially responded well, with scans showing no active cancer in his brain by early 2024.
New Cancer Diagnances and Metastasis (Early 2024)
By February 2024, new examinations revealed cancer in multiple sites, including his liver and brain, indicating widespread disease. At that point, his medical team concluded the cancer was terminal. Carter and his family shifted focus from curative treatments to comfort care, choosing to remain at home with hospice support rather than pursuing further aggressive hospital-based therapies.
Hospice Enrollment and Care Setting
In February 2024, Carter began receiving hospice care at his Plains residence. Hospice is a Medicare-covered benefit designed for individuals with a prognosis of six months or less if the disease follows its typical course. It prioritizes symptom management, dignity, and family presence over life-prolonging interventions. Carter’s medical order reflected this restrictive, comfort-focused plan.
Medicare Hospice Benefit and Documentation
Under Medicare, hospice eligibility requires certification that the patient has a terminal illness with a life expectancy of six months or less, as documented by two physicians. Patients must also sign a hospice election form, waiving curative treatments covered under Part A and, if enrolled, Part B. Carter’s care would have aligned with these criteria, focusing on pain and symptom control rather than on therapies aimed at curing or significantly prolonging life.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Date of Death | December 29, 2024 | Official announcement, family/Carter Center |
| Age at Death | 99 years old | Obituary and biographical records |
| Primary Diagnoses | Metastatic melanoma, later multi-site cancer (liver, brain) | Carter Center statements, medical reports |
| Hospice Start | February 2024 | Family/Carter Center disclosures |
| Place of Death | Plains, Georgia, home | Official obituary and news reports |
Causes of Death and Medical Context
While specific organ failure or exact physiological mechanisms were not detailed in public statements, the underlying cause was clearly advanced cancer. Metastatic melanoma and its later spread to the liver and brain can lead to multiple system failures, including liver dysfunction, neurological decline, and impaired immunity. In hospice settings, common terminal events include sepsis, respiratory failure, or complications from cachexia and weakness. Carter’s care team respected family privacy, so granular clinical details were not released beyond confirming that his death aligned with his known terminal condition.
Family Wishes and Public Communication
Throughout Carter’s final year, his family and the Carter Center consistently emphasized his desire for a peaceful and private passing. Statements were issued only when necessary, focusing on gratitude for support and respect for his wishes. This communication strategy reduced speculative reporting and reinforced that his death was neither sudden nor unexpected, but the culmination of a documented terminal illness managed at home.
Palliative Care Principles in Terminal Illness
Hospice care does not seek to reverse disease but to optimize quality of life by managing pain, dyspnea, agitation, and other distressing symptoms. The decision to remain at home often reflects a preference for familiar surroundings and family presence. In Carter’s case, this choice aligned with his long-standing emphasis on humility, service, and a quiet end of life. Understanding palliative goals helps explain why his care shifted away from hospitalization and toward comfort measures in the last months.
Distinguishing Terminal Illness Trajectory
Not all cancers follow the same course. While some patients respond for years to treatment, others experience rapid progression despite intervention. Carter’s clinical course—initial response to therapy, later multi-site recurrence, and decision for hospice—fits a pattern seen in widely metastatic melanoma and hepatobiliary involvement. This progression helps clarify why, by early 2024, curative options were no longer viable and focus shifted entirely to palliative support.